Lynn Diana Feild
Supervisory Patent Examiner (ID: 10328, Phone: (571)272-2092 , Office: P/2400 )
| Most Active Art Unit | 2835 |
| Art Unit(s) | 2445, 2616, 2400, 2103, 2899, 2835, 3307, 2431 |
| Total Applications | 631 |
| Issued Applications | 538 |
| Pending Applications | 24 |
| Abandoned Applications | 70 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6911823
[patent_doc_number] => 20050175581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Biological entities and the pharmaceutical and diagnostic use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/021951
[patent_app_country] => US
[patent_app_date] => 2004-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 48766
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20050175581.pdf
[firstpage_image] =>[orig_patent_app_number] => 11021951
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/021951 | Biological entities and the pharmaceutical and diagnostic use thereof | Dec 21, 2004 | Abandoned |
Array
(
[id] => 7069012
[patent_doc_number] => 20050244395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Targeted enzyme prodrug therapy'
[patent_app_type] => utility
[patent_app_number] => 11/008049
[patent_app_country] => US
[patent_app_date] => 2004-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 38012
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20050244395.pdf
[firstpage_image] =>[orig_patent_app_number] => 11008049
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/008049 | Targeted enzyme prodrug therapy | Dec 8, 2004 | Abandoned |
Array
(
[id] => 7111178
[patent_doc_number] => 20050208633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'SUGAR KINASES WITH EXPANDED SUBSTRATE SPECIFICITY AND THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 10/904941
[patent_app_country] => US
[patent_app_date] => 2004-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11737
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208633.pdf
[firstpage_image] =>[orig_patent_app_number] => 10904941
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/904941 | Sugar kinases with expanded substrate specificity and their use | Dec 5, 2004 | Issued |
Array
(
[id] => 5613541
[patent_doc_number] => 20060115469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Interstitial collagenase molecular motor'
[patent_app_type] => utility
[patent_app_number] => 11/001108
[patent_app_country] => US
[patent_app_date] => 2004-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6544
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20060115469.pdf
[firstpage_image] =>[orig_patent_app_number] => 11001108
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/001108 | Interstitial collagenase molecular motor | Nov 30, 2004 | Abandoned |
| 10/999109 | Novel human protease and polynucleotides encoding the same | Nov 28, 2004 | Abandoned |
Array
(
[id] => 7243824
[patent_doc_number] => 20050271679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Recombinant adenylate cyclase toxin of Bordetella induces T cell responses against tumoral antigens'
[patent_app_type] => utility
[patent_app_number] => 10/994204
[patent_app_country] => US
[patent_app_date] => 2004-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10164
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0271/20050271679.pdf
[firstpage_image] =>[orig_patent_app_number] => 10994204
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/994204 | Recombinant adenylate cyclase toxin of Bordetella induces T cell responses against tumoral antigens | Nov 21, 2004 | Abandoned |
Array
(
[id] => 9026348
[patent_doc_number] => 08535927
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-09-17
[patent_title] => 'Micrococcineae serine protease polypeptides and compositions thereof'
[patent_app_type] => utility
[patent_app_number] => 10/576331
[patent_app_country] => US
[patent_app_date] => 2004-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 40
[patent_no_of_words] => 146354
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10576331
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/576331 | Micrococcineae serine protease polypeptides and compositions thereof | Nov 18, 2004 | Issued |
Array
(
[id] => 6911843
[patent_doc_number] => 20050175601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Use of LIMK-1, its analogues and ligands for the production of a medicament against a thrombus formation or blood clotting disease'
[patent_app_type] => utility
[patent_app_number] => 10/991172
[patent_app_country] => US
[patent_app_date] => 2004-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8982
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20050175601.pdf
[firstpage_image] =>[orig_patent_app_number] => 10991172
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/991172 | Use of LIMK-1, its analogues and ligands for the production of a medicament against a thrombus formation or blood clotting disease | Nov 16, 2004 | Abandoned |
Array
(
[id] => 7688930
[patent_doc_number] => 20070105768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Dry recombinant human alpha 1-antitrypsin formulation '
[patent_app_type] => utility
[patent_app_number] => 10/578692
[patent_app_country] => US
[patent_app_date] => 2004-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2996
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20070105768.pdf
[firstpage_image] =>[orig_patent_app_number] => 10578692
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/578692 | Dry recombinant human alpha 1-antitrypsin formulation | Nov 9, 2004 | Abandoned |
| 10/980986 | Novel human proteins and polynucleotides encoding the same | Nov 3, 2004 | Abandoned |
Array
(
[id] => 7143903
[patent_doc_number] => 20050118632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Polynucleotides and polypeptides encoding a novel metalloprotease, Protease-40b'
[patent_app_type] => utility
[patent_app_number] => 10/980669
[patent_app_country] => US
[patent_app_date] => 2004-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 135610
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20050118632.pdf
[firstpage_image] =>[orig_patent_app_number] => 10980669
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/980669 | Polynucleotides and polypeptides encoding a novel metalloprotease, Protease-40b | Nov 2, 2004 | Abandoned |
Array
(
[id] => 5236452
[patent_doc_number] => 20070128609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'Ddr2 protein with activated kinase activity and preparation method thereof'
[patent_app_type] => utility
[patent_app_number] => 10/595585
[patent_app_country] => US
[patent_app_date] => 2004-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12946
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20070128609.pdf
[firstpage_image] =>[orig_patent_app_number] => 10595585
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/595585 | Ddr2 protein with activated kinase activity and preparation method thereof | Oct 31, 2004 | Abandoned |
Array
(
[id] => 7103977
[patent_doc_number] => 20050106703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Microorganisms producing dipeptides and process for producing dipeptides using the microorganisms'
[patent_app_type] => utility
[patent_app_number] => 10/976042
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 21754
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20050106703.pdf
[firstpage_image] =>[orig_patent_app_number] => 10976042
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/976042 | Microorganisms producing dipeptides and process for producing dipeptides using the microorganisms | Oct 28, 2004 | Abandoned |
Array
(
[id] => 7038865
[patent_doc_number] => 20050158299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Non-pancreatic proteases for controlling plasma cholecystokinin (CCK) concentration and for treating pain'
[patent_app_type] => utility
[patent_app_number] => 10/977737
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15373
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158299.pdf
[firstpage_image] =>[orig_patent_app_number] => 10977737
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/977737 | Treating abdominal pain due to pancreatitis with seaprose | Oct 28, 2004 | Issued |
Array
(
[id] => 5637509
[patent_doc_number] => 20060068482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Taspase1 and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/974127
[patent_app_country] => US
[patent_app_date] => 2004-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 15839
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20060068482.pdf
[firstpage_image] =>[orig_patent_app_number] => 10974127
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/974127 | Taspase1 and methods of use | Oct 25, 2004 | Abandoned |
Array
(
[id] => 4995071
[patent_doc_number] => 20070010416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-11
[patent_title] => 'Protease with improved stability in detergents'
[patent_app_type] => utility
[patent_app_number] => 10/576491
[patent_app_country] => US
[patent_app_date] => 2004-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15475
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20070010416.pdf
[firstpage_image] =>[orig_patent_app_number] => 10576491
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/576491 | Protease with improved stability in detergents | Oct 21, 2004 | Abandoned |
Array
(
[id] => 6966505
[patent_doc_number] => 20050233402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Heparinase III HLGAG fragments and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/967067
[patent_app_country] => US
[patent_app_date] => 2004-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 27371
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20050233402.pdf
[firstpage_image] =>[orig_patent_app_number] => 10967067
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/967067 | Heparinase III HLGAG fragments and uses thereof | Oct 13, 2004 | Abandoned |
Array
(
[id] => 463054
[patent_doc_number] => 07238509
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-03
[patent_title] => 'β 1,4-N-acetylgalactosaminyl transferases from C. jejuni'
[patent_app_type] => utility
[patent_app_number] => 10/962235
[patent_app_country] => US
[patent_app_date] => 2004-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 26053
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/238/07238509.pdf
[firstpage_image] =>[orig_patent_app_number] => 10962235
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/962235 | β 1,4-N-acetylgalactosaminyl transferases from C. jejuni | Oct 7, 2004 | Issued |
Array
(
[id] => 686492
[patent_doc_number] => 07078207
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-07-18
[patent_title] => 'Polypeptides having β-1,4-GalNAc transferase activity'
[patent_app_type] => utility
[patent_app_number] => 10/961882
[patent_app_country] => US
[patent_app_date] => 2004-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 26039
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/078/07078207.pdf
[firstpage_image] =>[orig_patent_app_number] => 10961882
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/961882 | Polypeptides having β-1,4-GalNAc transferase activity | Oct 7, 2004 | Issued |
Array
(
[id] => 520388
[patent_doc_number] => 07189836
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-13
[patent_title] => 'Nucleic acids encodingβ 1,4-N-acetylgalactosaminyltransferases from C. jejuni'
[patent_app_type] => utility
[patent_app_number] => 10/962334
[patent_app_country] => US
[patent_app_date] => 2004-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 26061
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/189/07189836.pdf
[firstpage_image] =>[orig_patent_app_number] => 10962334
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/962334 | Nucleic acids encodingβ 1,4-N-acetylgalactosaminyltransferases from C. jejuni | Oct 7, 2004 | Issued |